code stringlengths 4 12 | description stringlengths 2 264 | codetype stringclasses 8
values | context stringlengths 160 15.5k |
|---|---|---|---|
85999 | HC EOSINOPHIL COUNT | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
80500 | Lab pathology consultation | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
88300 | SURGICAL TISSUE, GROSS ONLY | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
82000 | Assay of blood acetaldehyde | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
81099 | URINE COLLECTION | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
88399 | HC UNLISTED SURGICAL PATHOLOGY PROCEDURE | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
81000 | HC URINALYSIS, BY DIP STICK OR TABLET REAGENT; NON-AUTOMATED, WI | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
88104 | HC CYTOPATHOLOGY, FLUIDS, WASHINGS OR BRUSHINGS, EXCEPT CERVICAL | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
81479 | UNLISTED MOLECULAR PATHOLOGY PROCEDURE | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
87001 | Small animal inoculation | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
85002 | HC BLEEDING TIME | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
88000 | Autopsy (necropsy) gross | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
81200 | HC UNIVERSAL CARRIER SCREEN | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
84999 | UNLISTED CHEMISTRY PROCEDURE | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
80100 | DRUG SCREEN QUALITATE/MULTI | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
88199 | Unlisted cytopathology px | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
80502 | Lab pathology consultation | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
87999 | HC UNLISTED MICROBIOLOGY PROCEDURE | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
80104 | Drug scrn 1+ class nonchromo | HCPCS | It contains detailed descriptions of each procedure and any associated equipment costs and facility fees that may be involved with performing said procedure/treatment on a patient at an institution like yours! - HCPCS (Healthcare Common Procedure Coding System) – Another widely-used coding system that provides more spe... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | Patients then place an ear-cuff in the external ear canal and treat themselves for 3 minutes, 3 times daily. Treatment is continued for as long as patients find themselves in a period of attacks of vertigo. In 1999, the Meniett® device (Medtronic, Minneapolis, MN) received clearance to market through a U.S. Food and Dr... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | In 1999, the Meniett® device (Medtronic, Minneapolis, MN) received clearance to market through a U.S. Food and Drug Administration (FDA) 510(k) process specifically as a symptomatic treatment of Meniere's disease. Transtympanic micropressure applications as a treatment of Meniere`s disease are considered investigationa... |
A4638 | Repl batt pulse gen sys | HCPCS | 2012. Available online at: http://guidance.nice.org.uk/IPG426/Guidance/pdf/English. Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for t... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | 2012. Available online at: http://guidance.nice.org.uk/IPG426/Guidance/pdf/English. Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for t... |
A4638 | Repl batt pulse gen sys | HCPCS | Available online at: http://guidance.nice.org.uk/IPG426/Guidance/pdf/English. Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympani... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | Available online at: http://guidance.nice.org.uk/IPG426/Guidance/pdf/English. Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympani... |
A4638 | Repl batt pulse gen sys | HCPCS | Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympanic treatment of inner ear endolymphatic fluid|
|ICD-10-CM (effective 10/1/15)||... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | Last accessed July 2014. |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympanic treatment of inner ear endolymphatic fluid|
|ICD-10-CM (effective 10/1/15)||... |
A4638 | Repl batt pulse gen sys | HCPCS | |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympanic treatment of inner ear endolymphatic fluid|
|ICD-10-CM (effective 10/1/15)||Investigational for all d... |
E2120 | Pulse gen sys tx endolymp fl | HCPCS | |ICD-9 Diagnosis||Investigational for all diagnoses|
|386.00 – 386.04||Meniere`s disease code range|
|HCPCS||A4638||Replacement battery for patient-owned ear generator, each|
|E2120||Pulse generator system for tympanic treatment of inner ear endolymphatic fluid|
|ICD-10-CM (effective 10/1/15)||Investigational for all d... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
G0364 | HC BONE MARROW ASPIRATE & BIOPSY | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
J9999 | Not otherwise classified, antineoplastic drugs | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
38230 | PR BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
86812 | Immunologic analysis for autoimmune disease, A, B, or C, single antigen | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
86822 | Lymphocyte culture primed | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
38204 | PR MGMT RCP HEMATOP PROGENITOR CELL DONOR &ACQUISJ | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
G0355 | CHEMO ADMN SUBQ/IM NONHORMONAL ANTINEOPLASTIC | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated a... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0364 | HC BONE MARROW ASPIRATE & BIOPSY | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
J9999 | Not otherwise classified, antineoplastic drugs | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
38230 | PR BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
86812 | Immunologic analysis for autoimmune disease, A, B, or C, single antigen | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
86822 | Lymphocyte culture primed | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
38204 | PR MGMT RCP HEMATOP PROGENITOR CELL DONOR &ACQUISJ | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0355 | CHEMO ADMN SUBQ/IM NONHORMONAL ANTINEOPLASTIC | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
G0364 | HC BONE MARROW ASPIRATE & BIOPSY | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
J9999 | Not otherwise classified, antineoplastic drugs | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
38230 | PR BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
86812 | Immunologic analysis for autoimmune disease, A, B, or C, single antigen | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
86822 | Lymphocyte culture primed | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
38204 | PR MGMT RCP HEMATOP PROGENITOR CELL DONOR &ACQUISJ | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
G0355 | CHEMO ADMN SUBQ/IM NONHORMONAL ANTINEOPLASTIC | HCPCS | POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA policy # 8.01.28 per approval by Medical Policy Advisory Committee (MPAC)
6/25/2004: Code Reference section completed
11/18/2004: Review... |
86816 | HC HLA TYPING DR/DQ SINGLE AG | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86826 | Hla x-match noncytotoxc addl | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
S2140 | Cord blood harvesting for transplantation, allogeneic | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86821 | Lymphocyte culture mixed | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86813 | HC HLA TYPING; A, B, OR C, MULTIPLE ANTIGENS | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86822 | Lymphocyte culture primed | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86812 | Immunologic analysis for autoimmune disease, A, B, or C, single antigen | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86825 | X-MATCHAHG | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86817 | HC HLA TYPING; DR/DQ, MULTIPLE ANTIGENS | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
S2142 | Cord blood-derived stem-cell transplantation, allogeneic | HCPCS | Policy statement reworded and ependymoma and embryonal CNS tumors are addressed separately. FEP and State and School Employee verbiage added to the Policy Exceptions section. Added new CPT codes 86825 and 86826. Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140... |
86816 | HC HLA TYPING DR/DQ SINGLE AG | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
G0267 | Bone marrow or psc harvest | CPT | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
S2140 | Cord blood harvesting for transplantation, allogeneic | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
G0265 | Cryopresevation Freeze+stora | CPT | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
86813 | HC HLA TYPING; A, B, OR C, MULTIPLE ANTIGENS | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
86822 | Lymphocyte culture primed | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
86812 | Immunologic analysis for autoimmune disease, A, B, or C, single antigen | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
G0266 | Thawing + expansion froz cel | CPT | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
86821 | Lymphocyte culture mixed | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
86817 | HC HLA TYPING; DR/DQ, MULTIPLE ANTIGENS | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
S2142 | Cord blood-derived stem-cell transplantation, allogeneic | HCPCS | Removed CPT codes 86812, 86813, 86816, 86817, 86821, and 86822 from the non-covered table. Added HCPCS S2140 and S2142 to the non-covered table. Deleted HCPCS G0265, G0266, and G0267 from the code section as these codes were deleted on 12/31/2007. 12/28/2010: Policy reviewed; no changes. 01/17/2012: Policy reviewed; no... |
15001 | Wound prep, addl 100 sq cm | HCPCS | For additional information on the MS-DRG system, including yearly reviews and changes to the Madras, please view prior Inpatient Prospective Payment System (IPS) proposed and final rules located in the left navigational area of this page. CMS is hosting a listening session that will describe the Medicare-Severity Diagn... |
15001 | Wound prep, addl 100 sq cm | HCPCS | CMS is hosting a listening session that will describe the Medicare-Severity Diagnosis-Related Group (MDR) Complication and Comorbidity (CC)/Major Complication and Comorbidity (MCC) Comprehensive Analysis discussed in the FY 2020 Inpatient Prospective Payment System (IPS) proposed and final rules. This listening session... |
15001 | Wound prep, addl 100 sq cm | HCPCS | This listening session will include review of the methodology to measure the impact on resource use and will provide an opportunity for CMS to receive public input on this analysis and to address any clarifying questions in order to assist the public in formulating written comments on the current severity level designa... |
1744 | Endoscopic robotic assisted procedure | ICD | 2009, 30 (6): 1297-1305. 10.1016/j.ridd.2009.05.006.PubMedView ArticleGoogle Scholar
- World Health Organization (WHO): International Classification of Diseases; tenth Edition (ICD-10) Diagnostic Criteria for Research. 1993, WHO GenevaGoogle Scholar
- Bakare MO, Ubochi VN, Okoroikpa IN, Aguocha CM, Ebigbo PO: Agreement... |
1500 | New Technology - Level 1 | APC | Complete list of Medical Abbreviations by. Acronym Finder, All Rights Reserved. PSP, HIPAA
CPT is defined as Common Procedural Terminology (medical) very frequently. © 1988-2021,
This book is an invaluable tool for everyone involved in learning, reading, writing or interpreting medical terminology. ChiroCode.com for Ch... |
1500 | New Technology - Level 1 | APC | PSP, HIPAA
CPT is defined as Common Procedural Terminology (medical) very frequently. © 1988-2021,
This book is an invaluable tool for everyone involved in learning, reading, writing or interpreting medical terminology. ChiroCode.com for Chiropractors CMS 1500 Claim Form Code-A-Note - Computer Assisted Coding Codapedia... |
1500 | New Technology - Level 1 | APC | © 1988-2021,
This book is an invaluable tool for everyone involved in learning, reading, writing or interpreting medical terminology. ChiroCode.com for Chiropractors CMS 1500 Claim Form Code-A-Note - Computer Assisted Coding Codapedia.com - Coding Forum Q&A CPT Codes DRGs & APCs DRG Grouper E/M Guidelines HCPCS Codes H... |
G0358 | IV PUSH TECHNIQUE EACH ADD SUBSTANCE/DRUG | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0360 | Each additional hr 1-8 hrs | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0363 | IRRIG IMPLANTED VENOUS ACESS DEVICE DRUG DEL SYS | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0364 | HC BONE MARROW ASPIRATE & BIOPSY | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0362 | Each add sequential infusion | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
J9999 | Not otherwise classified, antineoplastic drugs | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0359 | Chemotherapy IV one hr initi | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
38230 | PR BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0361 | Prolong chemo infuse>8hrs pu | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0357 | IV PUSH TECHNIQUE SINGLE/INIT SUBSTANCE/DRUG | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0356 | HORMONAL ANTINEOPLASTIC | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0355 | CHEMO ADMN SUBQ/IM NONHORMONAL ANTINEOPLASTIC | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
G0358 | IV PUSH TECHNIQUE EACH ADD SUBSTANCE/DRUG | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0360 | Each additional hr 1-8 hrs | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0363 | IRRIG IMPLANTED VENOUS ACESS DEVICE DRUG DEL SYS | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0364 | HC BONE MARROW ASPIRATE & BIOPSY | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
G0362 | Each add sequential infusion | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY3/25/2004: See policy "High-Dose Chemotherapy with Hematopoietic Stem Cell Support for Malignancies" prior to 3/25/2004, separate policy developed and aligned with BCBSA... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.